|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 409/10 | |
| A61K 31/381 | |||
| A61P 3/00 |
| (11) | Number of the document | 2994468 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14724380.2 |
| Date of filing the European patent application | 2014-05-07 | |
| (97) | Date of publication of the European application | 2016-03-16 |
| (45) | Date of publication and mention of the grant of the patent | 2017-07-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2014/059281 |
| Date | 2014-05-07 |
| (87) | Number | WO 2014/180872 |
| Date | 2014-11-13 |
| (30) | Number | Date | Country code |
| 13166940 | 2013-05-08 | EP | |
| 14155190 | 2014-02-14 | EP |
| (72) |
SELIC, Lovro, SI
HOTTER, Andreas, AT
LANGES, Christoph, AT
GRIESSER, Ulrich, AT
|
| (73) |
LEK Pharmaceuticals d.d.,
Verovskova 57, 1526 Ljubljana,
SI
|
| (54) | CRYSTALLINE HYDRATES OF 1-(BETA-D-GLUCOPYRANOSYL)-4-METHYL-3-[5-(4-FLUOROPHENYL)-2-THIENYLMETHYL]BENZENE |
| CRYSTALLINE HYDRATES OF 1-(BETA-D-GLUCOPYRANOSYL)-4-METHYL-3-[5-(4-FLUOROPHENYL)-2-THIENYLMETHYL]BENZENE |